4582 — SymBio Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- ¥5bn
- ¥4bn
- ¥2bn
Annual cashflow statement for SymBio Pharmaceuticals, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,001 | 2,106 | -1,195 | -3,807 | -4,749 |
| Depreciation | |||||
| Non-Cash Items | 315 | -439 | 432 | 54.5 | 394 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,270 | -138 | 472 | 336 | -221 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 140 | 1,628 | -195 | -3,417 | -4,576 |
| Capital Expenditures | -63.8 | -47.6 | -233 | -46.9 | -82.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -7.01 | 0.431 | -144 | 42.9 | 6.56 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -70.8 | -47.1 | -377 | -3.96 | -75.9 |
| Financing Cash Flow Items | -4 | -32.1 | -11.5 | -19.7 | -6.78 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -71.9 | 628 | 680 | 708 | 3,622 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.5 | 2,422 | 234 | -2,553 | -1,080 |